<DOC>
	<DOCNO>NCT02698956</DOCNO>
	<brief_summary>This international , mutli-center , prospective , consecutively enrol , observational registry . 2000 patient plan enrol one year 150 participating site . 300 patient 2000 patient enrol main registry plan consecutively enrol select sit study valve performance . Echocardiogram angiogram take routinely .</brief_summary>
	<brief_title>Observational Study Evaluate Safety Performance SAPIEN 3 THV System Real Life Practice .</brief_title>
	<detailed_description>The purpose registry provide clinical outcome safety information patient treat Edwards SAPIEN 3 Transcatheter Heart Valve delivery device severe , symptomatic calcific aortic stenosis . In addition , information collect serve post market safety surveillance regulatory obligation . Consecutive patient data collect baseline , procedure , discharge , discharge ( approx . 30 day post-index procedure ) , 12 month post-index procedure annually thereafter 5 year post-implant accord usual practice site .</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Patient suffer severe , symptomatic , calcific aortic stenosis STS Score ≥ 8 Logistic EuroSCORE ≥15 Congenital unicuspid congenital bicuspid aortic valve Evidence intracardiac mass Thrombus Vegetation Active infection endocarditis</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>SAPIEN 3 THV</keyword>
	<keyword>TAVI</keyword>
	<keyword>Transfemoral</keyword>
	<keyword>Transaortic</keyword>
	<keyword>Transapical</keyword>
	<keyword>Aortic valve</keyword>
</DOC>